Jefferies Starts Urovant Ltd. (UROV) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cowen Starts Urovant Ltd. (UROV) at Outperform
October 22, 2018 5:39 AM EDTCowen analyst Rita Baral initiates coverage on Urovant Ltd. (NASDAQ: UROV) with a Outperform rating and a price target of $25.00.
The analyst comments "We expect vibegron to be successful in Ph3 trial, based on positive Ph2 precedent, and to be approved for OAB.... More
JPMorgan Starts Urovant Ltd. (UROV) at Overweight
October 22, 2018 4:06 AM EDTJPMorgan initiates coverage on Urovant Ltd. (NASDAQ: UROV) with a Overweight rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Urovant Ltd. click here. For more ratings news on Urovant Ltd. click here.
Shares of Urovant Ltd. closed at $12.68 yesterday.
... More